Literature DB >> 11434681

Ectopic alphaIIbbeta3 integrin signaling involves 12-lipoxygenase- and PKC-mediated serine phosphorylation events in melanoma cells.

E Rásó1, J Tóvári, K Tóth, S Paku, M Trikha, K V Honn, J Tímár.   

Abstract

Megakaryocytic genes such as alphaIIbbeta3 can be expressed by malignant cells as part of the disturbances in their gene regulation. However, the function of the gene product greatly depends on the interaction of the ectopic protein with the new environment. The outside-in signaling of the ectopically expressed alphaIIbbeta3 integrin was studied in B16a murine melanoma cells using a monoclonal antibody, specifically directed to the activated conformation of alphaIIbbeta3, PAC-1 and the physiological ligand, fibrinogen. Ligation of alphaIIbbeta3 induced down-regulation of FAK but serine phosphorylation of three protein bands, 20/21, 85 and 140 kDa within 1-15 min. Flow cytometry indicated that the ligation of the receptor in B16a cells induces approximately 50% increase in phosphoserine positive cells within 5-15 min. 12-lipoxygenase is placed downstream in the signaling pathway, since ligation of alphaIIbbeta3 induces 12-HETE production within 5 min and pretreatment of tumor cells with select lipoxygenase inhibitior, Baicalein, prevents the increase in serine phosphorylation. Confocal microscopy of adherent tumor cells demonstrated rearrangement of actin filaments upon alphaIIbbeta3 ligation paralleled by downregulation of p125FAK and phoshotyrosine+ adhesion plaques and translocation of PKCalpha to stress fibers and cortical actin. PKC appears to be the major effector serine kinase of the alphaIIbbeta3-coupled signaling pathway, since pretreatment of tumor cells with a select PKC inhibitor, Calphostin C, prevents the ligation-induced serine phosphorylation. Previous studies have indicated a role for the 12-lipoxygenase-PKC signaling pathway in platelet aggregation as well as tumor invasion, therefore the involvement of this cascade in the signaling of the ectopic alphaIIbbeta3 integrin may partially explain its role in tumor progression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11434681

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  11 in total

1.  Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth.

Authors:  James V Michael; Jeremy G T Wurtzel; Guang Fen Mao; A Koneti Rao; Mikhail A Kolpakov; Abdelkarim Sabri; Nicholas E Hoffman; Sudarsan Rajan; Dhanendra Tomar; Muniswamy Madesh; Marvin T Nieman; Johnny Yu; Leonard C Edelstein; Jesse W Rowley; Andrew S Weyrich; Lawrence E Goldfinger
Journal:  Blood       Date:  2017-05-12       Impact factor: 22.113

Review 2.  Molecular pathology of tumor metastasis. I. Predictive pathology.

Authors:  J Tímár; O Csuka; Z Orosz; A Jeney; L Kopper
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

Review 3.  Molecular pathology of tumor metastasis III. Target array and combinatorial therapies.

Authors:  József Tímár; Andrea Ladányi; István Peták; András Jeney; László Kopper
Journal:  Pathol Oncol Res       Date:  2003-04-18       Impact factor: 3.201

4.  Protein kinase C regulation of 12-lipoxygenase-mediated human platelet activation.

Authors:  Jennifer Yeung; Patrick L Apopa; Joanne Vesci; Victor Kenyon; Ganesha Rai; Ajit Jadhav; Anton Simeonov; Theodore R Holman; David J Maloney; Olivier Boutaud; Michael Holinstat
Journal:  Mol Pharmacol       Date:  2011-12-09       Impact factor: 4.436

5.  Ligand-mimetic anti-alphaIIb beta3 antibody PAC-1 inhibits tyrosine signaling, proliferation and lung colonization of melanoma cells.

Authors:  Erzsébet Rásó; József Tóvári; Andrea Ladányi; Norbert Varga; József Tímár
Journal:  Pathol Oncol Res       Date:  2005-12-31       Impact factor: 3.201

6.  Inhibition of lung tumor colonization and cell migration with the disintegrin crotatroxin 2 isolated from the venom of Crotalus atrox.

Authors:  Jacob A Galán; Elda E Sánchez; Alexis Rodríguez-Acosta; Julio G Soto; Sajid Bashir; Mary Ann McLane; Carrie Paquette-Straub; John C Pérez
Journal:  Toxicon       Date:  2008-02-19       Impact factor: 3.033

7.  The protein kinase C inhibitor, H7, inhibits tumor cell invasion and metastasis in mouse melanoma via suppression of ERK1/2.

Authors:  Masanobu Tsubaki; Hiroshi Matsuoka; Chikako Yamamoto; Chisato Kato; Mitsuhiko Ogaki; Takao Satou; Tatsuki Itoh; Takashi Kusunoki; Yoshihiro Tanimori; Shozo Nishida
Journal:  Clin Exp Metastasis       Date:  2007-07-18       Impact factor: 5.150

8.  12-lipoxygenase activity plays an important role in PAR4 and GPVI-mediated platelet reactivity.

Authors:  J Yeung; P L Apopa; J Vesci; M Stolla; G Rai; A Simeonov; A Jadhav; P Fernandez-Perez; D J Maloney; O Boutaud; T R Holman; M Holinstat
Journal:  Thromb Haemost       Date:  2013-06-20       Impact factor: 5.249

9.  A novel tumor suppressor function of Kindlin-3 in solid cancer.

Authors:  Ibtissem Djaafri; Farah Khayati; Suzanne Menashi; Jorg Tost; Marie-Pierre Podgorniak; Aurelie Sadoux; Antoine Daunay; Luis Teixeira; Jean Soulier; Ahmed Idbaih; Niclas Setterblad; Françoise Fauvel; Fabien Calvo; Anne Janin; Celeste Lebbé; Samia Mourah
Journal:  Oncotarget       Date:  2014-10-15

Review 10.  Protease-activated receptors (PARs)--biology and role in cancer invasion and metastasis.

Authors:  Marek Z Wojtukiewicz; Dominika Hempel; Ewa Sierko; Stephanie C Tucker; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.